Strafford will be offering a webinar entitled "Orange Book Listing Recent Developments -- Impact on Prosecution of Pharmaceutical U.S. Patent Applications, Subsequent Orange Book Listings, Hatch Waxman Litigation" on February 14, 2023 from 1:00 to 2:30 pm (EST). Adriana L. Burgy, Mark J. Feldstein, Thomas L. Irving, and Jill K. MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Sarah Hooson of Merck Sharp & Dohme will guide patent counsel on recent Orange Book developments; discuss Orange Book listing practices and the implications for patent prosecution, listing, and litigation; and examine contemporary thought about Form 3542 and pitfalls to avoid. The webinar will review the following issues:
• What are the changes and anticipated changes to the Orange Book?
• What strategies should counsel employ when listing pharmaceutical patents in the Orange Book?
The registration fee for the webcast is $347. Those interested in registering for the webinar, can do so here.
Comments